Abstract
A (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazine as new potential MAO-B inhibitors. Computational study and in-silico prediction
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have